Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics
Nat Biotechnol
.
2017 Jun 7;35(6):500-502.
doi: 10.1038/nbt.3882.
Authors
Marc Hafner
1
,
Mario Niepel
1
,
Peter K Sorger
1
Affiliation
1
HMS LINCS Center, Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA.
PMID:
28591115
PMCID:
PMC5668135
DOI:
10.1038/nbt.3882
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
MeSH terms
Cell Line, Tumor / drug effects
Dose-Response Relationship, Drug*
Humans
Neoplasms / drug therapy*
Neoplasms / genetics
Pharmacogenetics*
Grants and funding
U54 HL127365/HL/NHLBI NIH HHS/United States